Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset
暂无分享,去创建一个
M. Toshner | J. Cannon | D. Jenkins | N. Screaton | Iryna Boubriak | A. Ruggiero | C. Ng | Joseph Newman
[1] M. Humbert,et al. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic , 2021, Orphanet Journal of Rare Diseases.
[2] M. Newnham,et al. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms , 2021, Thorax.
[3] Gary Alan Bass,et al. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans , 2020, The British journal of surgery.
[4] M. Humbert,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .
[5] J. Wild,et al. The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension , 2018, European Respiratory Journal.
[6] E. Vicaut,et al. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. , 2017, Journal of the American College of Cardiology.
[7] M. Madani,et al. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management , 2012, European Respiratory Review.
[8] H. Ghofrani,et al. Chronic thromboembolic pulmonary hypertension , 2004, European Respiratory Journal.
[9] K. Kerr,et al. Chronic thromboembolic pulmonary hypertension. , 2001, Clinics in chest medicine.
[10] W. Auger,et al. Chronic thromboembolic pulmonary hypertension. , 2009, Seminars in respiratory and critical care medicine.